Clinical trial / 2004
Genistein reduced daily hot flushes in postmenopausal women over one year
A randomized controlled trial allocated 90 healthy postmenopausal women aged 47 to 57 to daily genistein (54 mg), continuous estrogen-progestogen therapy, or placebo for 12 months. Compared to placebo, daily flushes decreased significantly with genistein by 22% (95% CI: -38 to -6.2) at 3 months, 29% (95% CI: -45 to -13) at 6 months, and 24% (95% CI: -43 to -5) at 12 months. No adverse uterine effects were observed.
- Study type
- Randomized controlled trial
- Who was studied
- 90 postmenopausal women aged 47 to 57
- What was measured
- hot flushes and endometrial thickness
THE PAPER
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study.
Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F. Menopause, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.